Table 2.
Gene | SNP | Chr | Alleles (min/maj) | Effect allele | RhinoGen Phenotype | P value | Beta coeff | Odds ratio (OR) | Lower 95% CI | Upper 95% CI |
---|---|---|---|---|---|---|---|---|---|---|
DDX58 | rs10738889 | 9 | G/A | A | Viral loss of asthma control | 0.0099 | 0.5097 | 0.2879 | 0.8750 | |
DDX58 | rs10738891 | 9 | T/G | G | Weeks infected | 0.0068 | 0.6158 | 0.2163 | 1.0152 | |
DDX58 | rs11795343 | 9 | C/T | T | Weeks infected | 0.0076 | −0.5780 | −0.7530 | −0.2015 | |
DDX58 | rs11795343 | 9 | C/T | T | Viral loss of asthma control | 0.0020 | 0.4243 | 0.2370 | 0.7297 | |
DDX58 | rs17289402 | 9 | A/G | G | Viral loss of asthma control | 0.0014 | 5.2311 | 1.6722 | 23.2345 | |
DDX58 | rs3205166 | 9 | G/T | T | Weeks infected | 0.0029 | −0.6637 | −1.0507 | −0.2766 | |
DDX58 | rs3205166 | 9 | G/T | T | Viral loss of asthma control | 0.0046 | 0.4540 | 0.2585 | 0.7719 | |
DDX58 | rs6476362 | 9 | C/T | T | Viral loss of asthma control | 0.0067 | 0.3873 | 0.1861 | 0.7669 | |
DDX58 | rs7034650 | 9 | G/A | A | Weeks infected | 0.0074 | −0.8616 | −1.4358 | −0.2873 | |
DDX58 | rs944581 | 9 | C/G | G | Weeks infected | 0.0073 | 0.5856 | 0.1928 | 0.9783 | |
| ||||||||||
EIF2AK2 | rs4233920 | 2 | A/G | G | Weeks infected | 0.0008 | 1.4456 | 0.4795 | 2.4116 | |
| ||||||||||
IFNB1 | rs10435777 | 9 | A/T | T | Cold symptom burden | 0.0014 | −10.882 | −16.814 | −4.9498 | |
IFNB1 | rs7849713 | 9 | C/G | G | Cold symptom burden | 0.0014 | −10.882 | −16.814 | −4.9498 | |
| ||||||||||
IL21 | rs2221903 | 4 | C/T | T | Weeks infected | 0.0056 | −0.6582 | −1.0724 | −0.2441 | |
| ||||||||||
IL28A | rs11671087 | 19 | C/T | T | Cold symptom burden | 0.0084 | −5.9473 | −10.705 | −1.1890 | |
| ||||||||||
IL8 | rs2227306 | 4 | C/T | T | Cold symptom burden | 0.0097 | −5.0177 | −8.9301 | −1.1053 | |
IL8 | rs2227306 | 4 | C/T | T | Viral loss of asthma control | 0.0036 | 0.4368 | 0.2392 | 0.7650 | |
| ||||||||||
JAK2 | rs6476939 | 9 | A/T | T | Number of illnesses | 0.0099 | −0.4496 | −0.7658 | −0.1334 | |
JAK2 | rs6476939 | 9 | A/T | T | Cold symptom burden | 0.0061 | −5.7245 | −9.5868 | −1.8622 | |
| ||||||||||
MX1 | rs459498 | 21 | A/G | G | Weeks infected | 0.0011 | −0.6561 | −1.0422 | −0.2699 | |
MX1 | rs467593 | 21 | G/A | A | Weeks infected | 0.0111 | −0.6896 | −1.1686 | −0.2106 | |
| ||||||||||
SCGB1A1 | rs2509973 | 11 | A/C | C | Cold symptom burden | 0.0018 | 6.3144 | 2.4981 | 10.1307 | |
| ||||||||||
STAT1 | rs11887698 | 2 | G/A | A | Number of illnesses | 0.0070 | −0.5265 | −0.9697 | −0.0833 | |
| ||||||||||
STAT4 | rs16833215 | 2 | G/A | A | Number of illnesses | 0.0085 | −0.4957 | −0.8408 | −0.1506 | |
STAT4 | rs16833249 | 2 | C/T | T | Number of illnesses | 0.0049 | −0.5064 | −0.8218 | −0.1910 | |
STAT4 | rs6434435 | 2 | A/G | G | Number of illnesses | 0.0122 | −0.5584 | −0.9715 | −0.1453 | |
| ||||||||||
VDR | rs12721370 | 12 | A/C | C | Weeks infected | 0.0105 | 1.0124 | 0.2930 | 1.7318 | |
VDR | rs4328262 | 12 | G/T | T | Cold symptom burden | 0.0055 | −6.2878 | −10.376 | −2.1996 | |
VDR | rs4328262 | 12 | G/T | T | Viral loss of asthma control | 0.0059 | 0.4045 | 0.2039 | 0.7601 | |
VDR | rs7139166 | 12 | C/G | G | Viral loss of asthma control | 0.0064 | 2.3272 | 1.2885 | 4.4188 |